Trial Site Detail
Drug: |
QINLOCK
Ripretinib
DCC-2618
SUTENT
Sunitinib |
|||
|---|---|---|---|---|
Trial: |
A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (intrigue) |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Active, not recruiting |
|||
Vanderbilt-Ingram Cancer Center2220 Pierce Ave. 691 Preston Building |
Principal Investigator: |
Vicki Keedy |
|---|---|
Contact: |
Vicki Keedy |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
Vanderbilt-Ingram Cancer Center Website: |
http://www.vicc.org/ct/ |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.